Friday, October 22

  • 08:25 AM - 08:30 AM
    Welcome and Announcements
  • 08:30 AM - 09:30 AM
    Enforcement Trends Update Linda Wawzenski, Deputy Chief Civil Division, US Attorney's Office
    • Understand why health care fraud statistics on criminal and civil cases can help your compliance program
    • Learn about COVID-19 fraud and how to avoid it
    • Review current DOJ priorities and their impact on health care fraud investigations
  • 09:30 AM - 09:45 AM
    Break
  • 09:45 AM - 10:45 AM
    OCR Enforcement Discretion: What to Expect Going Forward Marti Arvin, Executive Advisor, CynergisTek, Inc.
    • Describe the enforcement discretion exercised by OCR during the COVID-19 pandemic and identify likely change regarding enforcement post pandemic
    • Ascertain the likely impact of the 5th Circuit decision in MD Anderson v OCR on enforcement
    • Recognize the key implication of the proposed changes to the HIPAA regulations for a healthcare organization
  • 10:45 AM - 11:00 AM
    Break
  • 11:00 AM - 12:00 PM
    False Claims Act: Enforcement Priorities, Risk, and Remedies Michael Theis, Partner, Hogan Lovells LLP
    • Understand the current FCA enforcement priorities of the Department of Justice
    • Apply recent case developments and litigation trends to organizational compliance training and guidance
    • Define the hallmarks of effective compliance programs that reduce FCA risk
  • 12:00 PM - 01:00 PM
    Lunch (provided)
  • 01:00 PM - 02:00 PM
    Providing Telehealth During COVID-19: Key Issues to Consider Jayme Matchinski, Officer, Greensfelder, Hemker & Gale, P.C.
    • Provide an overview of regulatory issues related to the provision of Telehealth and Telemedicine
    • Identify key issues that impact the provision of Telemedicine during COVID-19
    • Define the next steps that providers should consider to avoid liability and enhance patient care
  • 02:00 PM - 02:15 PM
    Break
  • 02:15 PM - 03:15 PM
    Compliance Management of Physician Financial Arrangements: Commercial Reasonableness, FMV, Approval Process, and Payment Oversight in Light Final Stark Rules Heather Fields, Shareholder, Chair - Hospital/Health Systems Practice, Reinhart Boerner Van Deuren s.c. Robert Wade, Partner, Barnes & Thornburg LLP Adam Klein, Independent Advisor, Adam J Klein, LLC
    • Impact of new Final Stark Rule and current government view on common approaches to determining FMV and documenting Commercial Reasonableness
    • Market vs. Benchmark Data and how (and why) to transition from case-by-case FMV to an enterprise risk management approach
    • Hypothetical case study illustrating application to different types of relationships
  • 03:15 PM - 03:30 PM
    Break
  • 03:30 PM - 04:30 PM
    How to Respond to “I Heart That’s Illegal!” David Glaser, Shareholder, Fredrikson & Byron PA
    • Suggestions for improving your hiring process for compliance professionals
    • Tips for explaining complicated rules and the legal hierarchy to both compliance and medical professionals
    • Strategies for analyzing contradictory “expert” opinions and reducing the legal anxiety that can prompt employees to become eternal whistleblowers
    • Review examples of situations where compliance professionals correctly, or incorrectly, concluded something was illegal
Join our Social Network
Copyright © 2021 Health Care Compliance Association (HCCA). All rights reserved. All information provided through this site, including without limitation all information such as the "look and feel" of the site, data files, graphics, text, photographs, drawings, logos, images, sounds, music, video or audio files on this site, is owned and/or licensed by HCCA or its suppliers and is subject to United States and international copyright, trademark and other intellectual property laws. Any third party logos and/or content provided herein is owned by such third parties and is used by permission herein. Your use of this site to is subject to our Terms of Use and Privacy Statement.